These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4455619)

  • 21. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
    Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S
    Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunity to experimental cholera. I. Protective effect of humoral IgG antitoxin demonstrated by passive immunization.
    Pierce NF; Reynolds HY
    J Immunol; 1974 Sep; 113(3):1017-23. PubMed ID: 4413777
    [No Abstract]   [Full Text] [Related]  

  • 23. Current developments with cholera vaccines: "Where do we go from here?".
    Finkelstein RA
    Prog Clin Biol Res; 1980; 47():133-42. PubMed ID: 7010372
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanisms of disease and immunity in cholera: a review.
    Holmgren J; Svennerholm AM
    J Infect Dis; 1977 Aug; 136 Suppl():S105-12. PubMed ID: 197173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.
    Levine MM; Nalin DR; Craig JP; Hoover D; Bergquist EJ; Waterman D; Holley HP; Hornick RB; Pierce NP; Libonati JP
    Trans R Soc Trop Med Hyg; 1979; 73(1):3-9. PubMed ID: 442179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The mucosa immune system and immunization by intestinal infections].
    Deicher H
    Z Gastroenterol Verh; 1978; (14):37-47. PubMed ID: 88841
    [No Abstract]   [Full Text] [Related]  

  • 27. [Developmental aspects of organism immunoreactivity in vaccination against cholera (author's transl)].
    Gorkova AV; Kuznĕcov OR; Naumsina MS; Adamov AK
    Cesk Epidemiol Mikrobiol Imunol; 1975 May; 24(3):136-42. PubMed ID: 126811
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current problems of El Tor cholera].
    Solt K; Budai J; Vass A; Erdös L
    Orv Hetil; 1974 Mar; 115(9):488-91. PubMed ID: 4815452
    [No Abstract]   [Full Text] [Related]  

  • 29. Obtaining and Characteristic of Antibodies to Vibrio cholerae Protective Antigens Conjugated with Gold Nanoparticles.
    Dykman LA; Volokh OA; Gromova OV; Durakova OS; Vorobeva SA; Kireev MN; Livanova LF; Nikiforov AK; Shchyogolev SY; Kutyrev VV
    Dokl Biochem Biophys; 2020 Jan; 490(1):19-21. PubMed ID: 32342306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio cholerae.
    Nygren E; Holmgren J; Attridge SR
    Vaccine; 2008 Dec; 26(52):6784-90. PubMed ID: 18951939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of mucosal immunity.
    Lewis DJ; Hayward CM
    Methods Mol Med; 2003; 87():245-54. PubMed ID: 12958460
    [No Abstract]   [Full Text] [Related]  

  • 32. Simultaneous vaccination against cholera and yellow fever.
    Felsenfeld O; Wolf RH; Gyr K; Grant LS; Dutta NK
    Lancet; 1973 Mar; 1(7801):457-8. PubMed ID: 4120368
    [No Abstract]   [Full Text] [Related]  

  • 33. Cholera vaccines.
    Kabir S
    Lancet Infect Dis; 2007 Mar; 7(3):176-8; author reply 178. PubMed ID: 17317594
    [No Abstract]   [Full Text] [Related]  

  • 34. Colonization & protection in infant rabbits by a choleragenoid producing strain of Vibrio cholerae.
    Sinha VB; Srivastava BS
    Indian J Med Res; 1986 Aug; 84():139-41. PubMed ID: 3759164
    [No Abstract]   [Full Text] [Related]  

  • 35. [The excretion pattern and protective capacity in rabbits orally immunized with attenuated strains of Vibrio cholerae O1 biotype El Tor].
    García Sánchez HM; García Imia L; Oliva Hernández R; Pérez Quiñoy JL; Cedré Marrero B; Domínguez Iriarte R; Benítez Robles J
    Rev Cubana Med Trop; 1998; 50(2):115-9. PubMed ID: 10349429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-bound haemagglutinin (CHA) of V. cholerae 01 as protective antigen.
    Chaicumpa W; Boonthum A; Kalumbaheti T; Tapchaisri P
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):407-13. PubMed ID: 6523176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against mortality due to Vibrio cholerae infection in infant rabbits caused by immunization of mothers with cholera protective antigen.
    Sciortino CV
    J Diarrhoeal Dis Res; 1996 Mar; 14(1):16-26. PubMed ID: 8708328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cholera update and vaccination problems].
    Fournier JM; Villeneuve S
    Med Trop (Mars); 1998; 58(2 Suppl):32-5. PubMed ID: 9812307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholera and the immune response.
    Holmgren J; Svennerholm AM
    Prog Allergy; 1983; 33():106-19. PubMed ID: 6338509
    [No Abstract]   [Full Text] [Related]  

  • 40. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
    Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
    Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.